Jiangsu Hengrui Medicine Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Hengrui Medicine Co Ltd with three other
companies in this sector in China:
Tasly Pharmaceutical Group Company Limited
sales of 17.84 billion Chinese Renmimbi [US$2.66 billion]
Sichuan Kelun Pharmaceutical Company Limited
(16.35 billion Chinese Renmimbi [US$2.44 billion]
of which 99%
was Medical and Pharmaceutical Products), and
Beijing Tongrentang Co., Ltd.
(14.19 billion Chinese Renmimbi [US$2.12 billion]
of which 54%
was Retail Operation).
During the year ended December of 2018, sales at
Jiangsu Hengrui Medicine Co Ltd were 17.42 billion Chinese Renmimbi (US$2.60 billion).
increase of 25.9%
versus 2017, when the company's sales were 13.84 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jiangsu Hengrui Medicine Co Ltd
(and since 2013, sales have increased a total of 181%).
Sales of Other Businesses saw an increase
40.7% in 2018, from
11.56 million Chinese Renmimbi to 16.26 million Chinese Renmimbi.